Fresenius Kabi USA, LLC recalls Fresenius Kabi — Famotidine Injection, USP 20 mg per 2 mL
- Recall date
- November 7, 2025
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Fresenius Kabi USA, LLC, Fresenius Kabi
Why it was recalled
Out-of-specification endotoxin results — Potential Lack of sterility
What was recalled
Famotidine Injection, USP 20 mg per 2 mL
Read the official recall notice →
Get recall alerts
Free email alert whenever Fresenius Kabi USA, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fresenius Kabi USA, LLC, Fresenius Kabi